国: イギリス
言語: 英語
ソース: VMD (Veterinary Medicines Directorate)
Sulfadiazine, Trimethoprim
Schering-Plough Ltd
QJ01EW10
Sulfadiazine, Trimethoprim
Expired
Revised: 12 August 2009 AN: 00115/2009 SUMMARY OF PRODUCT CHARACTERISICS 1. NAME OF VETERINARY MEDICINAL PRODUCT Tribrissen Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCES MG / TABLET Sulfadiazine 400 Trimethoprim 80 For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Oral Tablet White, biconvex, branded scored tablets. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of alimentary tract infections, respiratory tract infections; urogenital tract infections; skin infections, general infections, infections of the ear and eye, also wounds. It may also be used for antibacterial medication in surgical cases where infection is likely to be present, e.g. with compound fractures and where there is established peritonitis. 4.3 CONTRA-INDICATIONS Do not administer to animals with known sulphonamide sensitivity, severe liver parenchymal damage nor blood dyscrasias. Do not administer in cases of severe renal impairment unless the dosage is reduced, adequate renal output is maintained and close veterinary supervision is available. 4.4 SPECIAL WARNINGS FOR TARGET SPECIES None Revised: 12 August 2009 AN: 00115/2009 4.5 SPECIAL PRECAUTIONS FOR USE i. Special precautions for use in animals Use of the product should be based on susceptibility testing and take into account official and local antimicrobial policies. ii. Special precautions to be taken by the person administering the product Take care to avoid skin contact. Wash hands after use. Sulphonamides may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to sulphonamides may lead to cross reactions with other antibiotics. Allergic reactions to these substances may occasionally be serious. 1. Do not handle this product if you know you are sensitive to sulphonamides. 2. If you develop symptoms following exposure such as a skin rash, you should seek medical advice and show the doctor this warning.” 4.6 ADVE 完全なドキュメントを読む